Latest news for PJX Resources (OTC:PJXRF) Stock

PJX Resources Inc is a mineral exploration company focused on building shareholder value and community opportunity through the exploration and development of mineral resources with a focus on gold, silver and base metals (zinc, lead, copper, nickel). The company's properties are located in the historical Sullivan Mine District and Vulcan Gold Belt near Cranbrook and Kimberley, British Columbia.

PJX Resources Inc

10x Genomics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) stock is trading lower after the company, on Wednesday, released preliminary financial results for the third quarter of 2024, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41259632/10x-genomics-announces-preliminary-select-third-quarter-2024-results" rel="noreferrer noopener">revealing a mixed performance</a>.
The company&#8217;s revenue for the quarter totaled approximately $151.7 million versus the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $162.245 million</a>, marking a slight 1% decline compared to the same period in 2023.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39716150/whats-going-on-with-10x-genomics-stock-on-wednesday" rel="noreferrer noopener">What&#8217;s Going On With 10x Genomics Stock On Wednesday</a>?
&#8220;Third-quarter revenue fell short of our expectations,&#8221; said Serge Saxonov, Co-founder and CEO of 10x Genomics. &#8220;The previously announced&nbsp;modifications we made to our commercial processes and organization to increase effectiveness represented a significant change in how we engage with customers. The transition was more disruptive than we anticipated, especially in the Americas. At the same time, our customers continue to be cautious with their spending, particularly around capital purchases, which notably impacted instrument sales during the quarter.&nbsp;
10x Genomics&#8217; instruments sales fell significantly, with a 46% drop to $19.1 million. This included $7.6 million from Chromium instruments and $11.4 million from Spatial instruments.
Consumables sales grew by 10%, reaching $126.2 million. Of this, Chromium consumables accounted for $96.5 million, and Spatial consumables generated $29.7 million.
Additionally, services revenue experienced a robust 48% growth, contributing $6.4 million.
Revenue trends varied geographically. The company saw an 11% decline in the Americas, bringing revenue to $87.8 million.
However, strong growth was reported in both EMEA and APAC regions, with 18% and 15% increases, respectively. EMEA revenue totaled $37.9 million, while APAC generated $26.0 million.
The company also reported cash and cash equivalents of approximately $398 million as of September 30, 2024.
The company plans to provide full guidance for the year during its earnings call on October 29, 2024.
During its second quarter 2024 earnings release, the gene sequencing company cut its fiscal year 2024 sales guidance to $640 million&nbsp;to&nbsp;$660 million&nbsp;from a prior range of&nbsp;$670 million&nbsp;to&nbsp;$690 million versus the consensus of $648.21 million.
Price Action: TXG stock is down 26.20% at $15.35 during the premarket session at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41257734/baxters-north-carolina-facility-manufactures-60-of-iv-fluids-and-peritoneal-dialysis-solutions-s" target="_blank" rel="noreferrer noopener">Baxter&#8217;s North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage</a>.</li>
</ul>

Earnings

News

Health Care

Movers

General

Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead

Theratechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THTX#NASDAQ">THTX</a>) lowers FY2024 sales outlook from $87.00 million-90.00 million to $83.00 million-85.00 million.

Guidance

THTX

Theratechnologies Lowers FY2024 Sales Guidance from $87.00M-90.00M to $83.00M-85.00M, Est $84.044M

Building on an earlier term sheet, this agreement calls for minimum royalty payments to YYEM of more than&nbsp;$30 million&nbsp;through 2026.

Connexa Sports Technologies Inc. - Common Stock

YYAI

Connexa Sports Technologies Enters Exclusive License Agreement With Guofu Enterprise Management; Expects Agreement To Generate In Excess Of $30M In License Income For YYEM Through End Of December 2026

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3 class="wp-block-heading">SunCoke Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXC#NYSE">SXC</a>)</h3>
<ul>
<li>Dividend Yield: 5.65%</li>
<li>Benchmark analyst Nathan Martin reiterated a Buy rating with a price target of $12 on May 2. This analyst has an accuracy rate of 65%.</li>
<li>B. Riley Securities analyst Lucas Pipes downgraded the stock from Buy to Neutral and cut the price target from $12 to $11 on Aug. 3, 2023. This analyst has an accuracy rate of 68%.</li>
<li>Recent News: On July 31, SunCoke Energy posted better-than-expected quarterly earnings.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101024&amp;t=be2bearmibe3na1">latest SXC news</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="898" height="820" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/10072934/image-72.png" alt="" class="wp-image-589236" style="width:682px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/10072934/image-72.png 898w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/10072934/image-72-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/10072934/image-72-768x701.png 768w" sizes="(max-width: 898px) 100vw, 898px" /></a></figure>
<h3 class="wp-block-heading">Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)</h3>
<ul>
<li>Dividend Yield: 5.24%</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained an Overweight rating and slashed the price target from $60 to $55 on Sept. 13. This analyst has an accuracy rate of 72%.</li>
<li>Fermium Research analyst Frank Mitsch maintained a Hold rating and cut the price target from $60 to $54 on Sept. 12. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: On Sept. 12, Dow updated its third-quarter revenue and EBITDA outlook, citing an unplanned event at a Texas ethylene cracker and greater input costs and margin compression in Europe.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101024&amp;t=be2bearmibe3na1">latest DOW news.</a></li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101024&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/1fbaa4f3-4fd4-4c79-89e5-65dcb03fc975" alt="" style="width:654px;height:auto" /></a></figure>
<h3 class="wp-block-heading">Mercer International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MERC#NASDAQ">MERC</a>)</h3>
<ul>
<li>Dividend Yield: 4.26%</li>
<li>CIBC analyst Hamir Patel maintained a Neutral rating and lowered the price target from $10 to $8.5 on Aug. 13. This analyst has an accuracy rate of 60%.</li>
<li>RBC Capital analyst Matthew McKellar maintained a Sector Perform rating and cut the price target from $10 to $8 on Aug. 12. This analyst has an accuracy rate of 71%.</li>
<li>Recent News: On Sept. 25, Mercer announced downtime at its Peace River Mill.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101024&amp;t=be2bearmibe3na1">trend in MERC stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="931" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/10073039/image-74.png" alt="" class="wp-image-589240" style="width:679px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/10073039/image-74.png 931w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/10073039/image-74-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/10073039/image-74-768x695.png 768w" sizes="(max-width: 931px) 100vw, 931px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41266054/s-p-settles-at-record-high-as-apple-amazon-shares-surge-investor-optimism-improves-ahead-of-inflati">S&amp;P Settles At Record High As Apple, Amazon Shares Surge: Investor Optimism Improves Ahead Of Inflation Data</a></li>
</ul>

Dividends

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

MERC

Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields

Theratechnologies Q3 2024 GAAP EPS $0.06 Beats $0.03 Estimate

Theratechnologies Q3 2024 Sales $22.600M Miss $23.981M Estimate

<a href="https://www.benzinga.com/real-estate/24/10/41182526/elon-musk-reportedly-already-moved-x-headquarters-from-san-francisco-to-this-little-known-location">Elon Musk </a>is no stranger to headlines, but his latest offer of free Starlink internet to Hurricane Helene victims has left many raising questions.&nbsp;
While SpaceX initially announced it would waive the $120 monthly subscription fee for the first month in affected areas, there's a significant caveat – victims still need to buy Starlink hardware, which costs between $300 and $400, including taxes and shipping. This added cost feels like a slap for people already dealing with the hurricane&#8217;s devastation.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li><a href="https://www.benzinga.com/money/62-years-old-with-1-mil-saved">I&#8217;m 62 Years Old And Have $1.2 Million Saved. Is This Enough to Retire Stress-Free?</a></li>
</ul>
The reaction on the ground has been a mix of gratitude and frustration. Reports from The Register highlighted the experience of a North Carolina resident, Kinney Baughman, who described the offer as a "bait and switch."&nbsp;
Beyond the cost, there's the issue of timing. Even if someone can scrape together the money for the hardware, delivery can take two to three weeks. By then, regular internet may already be back up and running, leaving many wondering if the purchase was necessary. After all, spending $400 on equipment that arrives after you've resolved your connectivity issues feels like pouring salt on the wound.
Trending: Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a>
Then there's the power problem. Many areas hit hardest by the hurricane are still without electricity, rendering a satellite dish useless until power is restored. It's not just the money – the logistics of it all seem off.
Critics quickly point out that Elon Musk, whose fortune is estimated at $260 billion according to Bloomberg, could have offered a more immediate, practical solution. Instead, as some have argued, this offer looks suspiciously like a marketing move disguised as charity.
See Also: How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.
And the controversy doesn't stop there. Musk has recently faced criticism for political donations that have raised eyebrows. Reports show that he's contributed tens of millions of dollars to far-right causes, including America First Legal, a group associated with former Trump advisor Stephen Miller.&nbsp;
Still, for some, the Starlink service is a game-changer. <a href="https://www.benzinga.com/news/24/09/40869627/elon-musk-now-controls-two-thirds-of-the-planets-satellites-and-spacex-is-just-getting-started-with">Satellite </a>internet could be a lifeline in remote areas where infrastructure recovery is slow. It's easy to see the appeal – connecting with emergency services, contacting family or getting reliable updates could be worth the upfront cost, even if it stings a little.
Read Next:
<ul>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a></li>
<li>A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> you can become part of the next big real estate boom today.</a></li>
</ul>

Personal Finance

Elon Musk's $260 Billion Empire Will Now Charge Helene Victims $400 For Internet – Are We Seeing Exploitation At Its Worst?

Offerings

IMTX

Immatics Plans $150M Public Offering Of Its Ordinary Shares

Needham analyst John Todaro reiterates Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) with a Buy and maintains $11 price target.

Reiteration

APLD

Needham Reiterates Buy on Applied Digital, Maintains $11 Price Target

Neogen&rsquo;s operations organization will transition to report to David H. Naemura, Chief Financial Officer. Mr. Jones will work closely with Mr. Naemura on this transition. Mr. Jones also will continue to lead the commercial organization until the Chief Commercial Officer role is filled and will oversee the transition of this function to his successor.

Management

NEOG

Neogen COO Douglas E. Jones Intends To Retire In Early 2025 - Filing

Immatics Filed For Mixed Shelf Offering; Size Not Disclosed

Goldman Sachs analyst Kash Rangan maintains Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) with a Buy and lowers the price target from $515 to $500.

MSFT

Goldman Sachs Maintains Buy on Microsoft, Lowers Price Target to $500

The increase reflects market performance and positive net flows in retail separate accounts, partially offset by net outflows in institutional accounts and open-end funds. Preliminary average AUM for the quarter was $176.0 billion.&nbsp;

VRTS

Virtus Investment Partners Reported Preliminary Assets Under Management Of $183.7B And Other Fee Earning Assets Of $2.4B For Total Client Assets Of $186.1B As Of September 30, 2024.

Needham analyst Joseph Stringer reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and maintains $320 price target.

ALNY

Needham Reiterates Buy on Alnylam Pharmaceuticals, Maintains $320 Price Target

FHTX

Foghorn Therapeutics Doses First Patient With FHD-909 In Phase 1 Trial For SMARCA4 (BRG1) Mutated Cancers, With Non-small Cell Lung Cancer As Primary Target Patient Population

Goldman Sachs analyst Charles Perron-Piche initiates coverage on Builders FirstSource (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>) with a Buy rating and announces Price Target of $225.

Initiation

BLDR

Goldman Sachs Initiates Coverage On Builders FirstSource with Buy Rating, Announces Price Target of $225

WIIM

Delta Air Lines shares are trading lower after the company reported Q3 earnings miss.

EscharEx against collagenase ointment (marketed as SANTYL in the U.S. and IRUXOL in Europe)&nbsp;

MDWD

Mediwound Will Initiate A Controlled, Multicenter Phase 2 Study For EscharEx Against Collagenase Ointment For Venous Leg Ulcers. Scheduled To Commence In 2025, This Phase 2 Study Will Run Concurrently With The Company's Phase 3 Trial

Goldman Sachs analyst Charles Perron-Piche initiates coverage on SiteOne Landscape Supply (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SITE#NYSE">SITE</a>) with a Neutral rating and announces Price Target of $158.

SITE

Goldman Sachs Initiates Coverage On SiteOne Landscape Supply with Neutral Rating, Announces Price Target of $158

HC Wainwright &amp; Co. analyst Ed Arce reiterates Enanta Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTA#NASDAQ">ENTA</a>) with a Buy and maintains $27 price target.

ENTA

HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $27 Price Target

PJX Resources bumps up private placement to sell up to 22M units

PJXRF

Press Releases

PJX Resources Announces Closing of Over Subscribed Non-Brokered Private Placement

PJX Resources Announces Non-Brokered Private Placement and Warrant Extension

PJX Resources Announces Amendment to Recently Completed Non-Brokered Private Placement

PJX Resources Announces Closing of Non-Brokered Private Placement

PJX Resources Discovers 5.57% Zinc Mineralization in Outcrop Above Recently Discovered Sullivan Style Massive Sulphide Boulders

PJX Resources Announces Non-Brokered Private Placement of $3.6 Million

PJX Resources Announces Closing of $3.6 Million Non-Brokered Private Placement

PJX Resources Provides Corporate Update and Welcomes New Advisors

PJX Resources Receives Permit to Drill Its Sullivan Deposit Style and Grade Mineralisation Discovery

PJX Resources' Drilling Identifies Venting Type Environment That Supports Sullivan Style Sedex Mineralisation

PJX Resources

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

PJX Resources

News

Latest news for PJX Resources (OTC:PJXRF) Stock